These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11764401)

  • 1. Verification of ophthalmic brachytherapy treatment planning.
    Packer K
    Australas Phys Eng Sci Med; 2001 Sep; 24(3):177-80. PubMed ID: 11764401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
    Poder J; Corde S
    Med Phys; 2013 Dec; 40(12):121709. PubMed ID: 24320495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation.
    Zimmermann LW; Amoush A; Wilkinson DA
    J Appl Clin Med Phys; 2015 Nov; 16(6):226-239. PubMed ID: 26699577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
    Knutsen S; Hafslund R; Monge OR; Valen H; Muren LP; Rekstad BL; Krohn J; Dahl O
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1159-66. PubMed ID: 11704341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric validation of the Theragenics AgX-100® I-125 seed for ROPES eye plaque brachytherapy.
    Pagulayan C; Heng SM; Corde S
    Australas Phys Eng Sci Med; 2019 Jun; 42(2):599-609. PubMed ID: 31087233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds.
    Luxton G; Astrahan MA; Liggett PE; Neblett DL; Cohen DM; Petrovich Z
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):167-76. PubMed ID: 3391814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the AAPM-TG43 dosimetry protocol for I-125 brachytherapy seed.
    Mobit P; Badragan I
    Phys Med Biol; 2004 Jul; 49(14):3161-70. PubMed ID: 15357189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial evaluation of Advanced Collapsed cone Engine dose calculations in water medium for I-125 seeds and COMS eye plaques.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Mar; 45(3):1276-1286. PubMed ID: 29383721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous dose calculations for Collaborative Ocular Melanoma Study eye plaques using actual seed configurations and Task Group Report 43 formalism.
    Deufel CL; Furutani KM
    Brachytherapy; 2015; 14(2):209-30. PubMed ID: 25533415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitioning from a COMS-based plaque brachytherapy program to using eye physics plaques and plaque simulator treatment planning system: A single institutional experience.
    Meltsner SG; Rodrigues A; Materin MA; Kirsch DG; Craciunescu O
    J Appl Clin Med Phys; 2023 May; 24(5):e13902. PubMed ID: 36637797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDR quality assurance methods for personal digital assistants.
    Astrahan MA
    Med Dosim; 2004; 29(3):166-72. PubMed ID: 15324912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry and physical treatment planning for iodine eye plaque therapy.
    Alberti W; Pothmann B; Tabor P; Muskalla K; Hermann KP; Harder D
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1087-92. PubMed ID: 2022510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.